Literature DB >> 3443256

Diurnal profile of pancreatic exocrine secretion and plasma levels of gut hormones (cholecystokinin and pancreatic polypeptide).

I Nakano1, A Funakoshi, H Shinozaki, K Miyazaki, K Tateishi, T Hamaoka.   

Abstract

We examined diurnal changes of pancreatic exocrine secretion and plasma levels of cholecystokinin (CCK) and human pancreatic polypeptide (hPP) in men with postoperative transient external pancreatic drainage (3 with pancreatico-jejunostomy: PJ, and 5 with pancreato-duodenectomy:PD). Plasma CCK levels increased and the pancreatic exocrine secretion showed a corresponding increase after meals in both groups. In the PJ group hPP levels increased after meals and there was a significant correlation between the plasma levels of CCK and hPP. In the PD group the plasma hPP levels were not detectable throughout the study and there was a better correlation between the exocrine secretion and the plasma CCK levels than in the PJ group. Plasma CCK levels showed rhythmic changes associated with pancreatic exocrine secretion, with no significant changes in plasma glucose and insulin in the night (24:00-07:00). These results suggested that (1) the resection of the pancreatic head which is rich in hPP contents led to a complete loss of anti-CCK effects on CCK, and that (2) fluctuation in plasma CCK levels, in the fasting state, might initiate pancreatic exocrine secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443256     DOI: 10.1007/BF02776749

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  13 in total

1.  Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats.

Authors:  G M Green; R L Lyman
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

2.  Pancreatic polypeptide and intestinal migrating motor complex in humans. Effect of pancreaticobiliary secretion.

Authors:  C Owyang; S R Achem-Karam; A I Vinik
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

3.  Relationships among canine interdigestive exocrine pancreatic and biliary flow, duodenal motor activity, plasma pancreatic polypeptide, and motilin.

Authors:  F B Keane; E P DiMagno; R R Dozois; V L Go
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

4.  Localization of pancreatic polypeptide cells in a limited lobe of the human neonate pancreas: remnant of the ventral primordium?

Authors:  J Rahier; J Wallon; W Gepts; J Haot
Journal:  Cell Tissue Res       Date:  1979-09-01       Impact factor: 5.249

5.  Trypsin as a regulator of pancreatic secretion in the rat.

Authors:  I Ihse; P Lilja; I Lundquist
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

6.  Diurnal profile of plasma motilin concentrations during fasting and feeding in man.

Authors:  A Funakoshi; L L Ho; K L Jen; R Knopf; A I Vinik
Journal:  Gastroenterol Jpn       Date:  1985-10

7.  Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay.

Authors:  S Himeno; S Tarui; S Kanayama; T Kuroshima; Y Shinomura; C Hayashi; K Tateishi; K Imagawa; E Hashimura; T Hamaoka
Journal:  Am J Gastroenterol       Date:  1983-11       Impact factor: 10.864

8.  Effect of partial exclusion of pancreatic juice on rat basal pancreatic secretion.

Authors:  K Miyasaka; G M Green
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

9.  Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man.

Authors:  G R Greenberg; R F McCloy; V S Chadwick; T E Adrian; J H Baron; S R Bloom
Journal:  Dig Dis Sci       Date:  1979-01       Impact factor: 3.199

10.  Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response.

Authors:  E Hashimura; F Shimizu; T Nishino; K Imagawa; K Tateishi; T Hamaoka
Journal:  J Immunol Methods       Date:  1982-12-30       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.